NHS to roll out MS vaccine that cuts hospital treatment time by 90%

Thousands of U.K. patients with MS will benefit from a 10-minute injection that slows the progression of disability while cutting their treatment time in hospital by over 90%. The NHS will be one of the first healthcare systems in the world to offer ocrelizumab via an infusion. The drug is usually given via twice-yearly IV infusions, which can take up to four hours.